login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
Social Capital Suvretta Holdings Corporation III (DNAC) Stock News
USA
-
Nasdaq
- NASDAQ:DNAC -
KYG8253W1096
-
Common Stock
9.28
-0.72 (-7.2%)
Last: 7/11/2022, 8:00:01 PM
9.6
+0.32 (+3.45%)
After Hours:
7/11/2022, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
DNAC Latest News, Press Relases and Analysis
All
Press Releases
3 years ago - By: Social Capital Suvretta Holdings Corp. III
Social Capital Suvretta Holdings Corp. III Announces Reconvened Extraordinary General Meeting of Shareholders
4 years ago - By: InvestorPlace
DNAC Stock: 11 Things to Know Ahead of the ProKidney SPAC Merger
4 years ago - By: InvestorPlace
- Mentions:
APPH
AESE
HOFV
BZFD
...
7 Worst SPACs for Smart Investors to Skip in 2022
4 years ago - By: Brodsky & Smith, LLC
- Mentions:
ZGNX
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Zogenix, Inc. (Nasdaq - ZGNX), Social Capital Suvretta Holdings Corp. III (Nasdaq - DNAC), Viveon Health Acquisition Corp. (NYSE American - VHAQ)
4 years ago - By: Benzinga
- Mentions:
RPRX
ProKidney Turns To Palihapitiya-Backed SPAC To Go Public In $2.6B Deal
4 years ago - By: InvestorPlace
- Mentions:
SOFI
LCID
RBLX
SOFI Stock: 11 Reasons Why Investors Are Banking On a SoFi Bank Charter
4 years ago - By: InvestorPlace
- Mentions:
RBLX
BLK
WMT
What Roblox Bulls Are Saying as RBLX Stock Trends Today
4 years ago - By: InvestorPlace
- Mentions:
IPOF
IPOD
RPRX
DNAC Stock Alert: Chamath Palihapitiya’s SPAC Preps for ProKidney Merger
4 years ago - By: Social Capital Suvretta Holdings Corp. III and ProKideny LP
Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to Become Publicly Traded via Business Combination with Social Capital Suvretta Holdings Corp. III
4 years ago - By: Benzinga
- Mentions:
AMGN
RPRX
SOFI
IPOD
...
2 Chamath Palihapitiya SPAC Deals Rumored: Will He Land The Year's First Deal Once Again?
4 years ago - By: InvestorPlace
- Mentions:
DNAA
DNAB
DNAD
Are Chamath Palihapitiya’s 4 New Biotech SPACs Worth a Look?
4 years ago - By: Social Capital Suvretta Holdings Corp. III
Social Capital Suvretta Holdings Corp. III Announces Pricing of Upsized $220,000,000 Initial Public Offering
Please enable JavaScript to continue using this application.